PROTECT Confirms Viable Oral Drug Delivery Technology
PROTECT is the first Phase III program to unequivocally demonstrate that oral delivery of macromolecules is feasible with Emisphere’s technology.
- Activity (absorption and effect in DVT reduction)
- Safety (No SAEs related to carrier)